Free Trial

Astronics (ATROB) Financials

Astronics logo
$30.00 -1.00 (-3.23%)
As of 05/23/2025 12:03 PM Eastern
Annual Income Statements for Astronics

Annual Income Statements for Astronics

This table shows Astronics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
-16 -26 -36 -26 -116 52 47 20 48 67 56
Consolidated Net Income / (Loss)
-16 -26 -36 -26 -116 52 47 20 48 67 56
Net Income / (Loss) Continuing Operations
-16 -26 -36 -26 -116 52 47 20 48 67 56
Total Pre-Tax Income
-7.87 -26 -30 -27 -112 68 52 25 69 94 79
Total Operating Income
26 -6.67 -30 -29 -101 1.70 64 32 75 99 87
Total Gross Profit
168 121 72 65 97 156 181 137 159 188 167
Total Revenue
795 689 535 445 503 773 803 624 633 692 661
Operating Revenue
795 689 535 445 503 773 803 624 633 692 661
Total Cost of Revenue
627 568 463 380 406 617 623 487 474 504 494
Operating Cost of Revenue
627 568 463 380 406 617 623 487 474 504 494
Total Operating Expenses
142 127 102 94 198 154 117 105 85 89 80
Selling, General & Admin Expense
142 127 102 99 111 143 117 89 85 89 80
Total Other Income / (Expense), net
-34 -20 0.25 1.71 -12 67 -11 -7.11 -6.10 -4.75 -8.26
Interest Expense
10 0.00 0.00 6.80 6.74 6.14 9.71 5.37 4.35 4.75 8.26
Interest & Investment Income
-22 -23 -9.42 - - - - - - - -
Other Income / (Expense), net
-2.19 3.69 9.67 8.52 -4.97 73 -1.67 -1.74 -1.74 - -
Income Tax Expense
8.35 0.11 5.95 -1.38 3.37 16 5.48 5.31 20 27 23
Basic Earnings per Share
($0.46) ($0.80) ($1.11) ($0.82) ($3.76) $1.62 $1.45 $0.60 $1.44 $2.29 $1.96
Weighted Average Basic Shares Outstanding
35.27M 34.52M 64.57M 31.52M 30.89M 30.72M 65.19M 28.59M 29.10M 25.43M 28.72M
Diluted Earnings per Share
($0.46) ($0.80) ($1.11) ($0.82) ($3.76) $1.60 $1.41 $0.58 $1.40 $2.22 $1.87
Weighted Average Diluted Shares Outstanding
35.27M 34.52M 64.57M 31.52M 30.89M 30.72M 65.19M 28.59M 29.10M 25.43M 28.72M
Weighted Average Basic & Diluted Shares Outstanding
35.27M 34.52M 64.57M 31.52M 30.89M 30.72M 65.19M 28.59M 29.10M 25.43M 28.72M

Quarterly Income Statements for Astronics

This table shows Astronics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/29/2025 12/31/2024 9/28/2024 6/29/2024 3/30/2024 12/31/2023 9/30/2023 7/1/2023 4/1/2023 12/31/2022 10/1/2022
Net Income / (Loss) Attributable to Common Shareholders
9.53 -2.83 -12 1.53 -3.18 6.98 -17 -12 -4.42 -6.78 -15
Consolidated Net Income / (Loss)
9.53 -2.83 -12 1.53 -3.18 6.98 -17 -12 -4.42 -6.78 -15
Net Income / (Loss) Continuing Operations
9.53 -2.83 -12 1.53 -3.18 6.98 -17 -12 -4.42 -6.78 -15
Total Pre-Tax Income
10 0.58 -5.17 1.26 -4.53 1.53 -21 -3.90 -3.13 -7.21 -17
Total Operating Income
13 8.88 8.37 7.55 1.67 7.78 -14 2.40 -2.37 -3.17 -14
Total Gross Profit
61 50 43 41 34 40 21 33 28 22 14
Total Revenue
206 209 204 198 185 195 163 174 157 158 131
Operating Revenue
206 209 204 198 185 195 163 174 157 158 131
Total Cost of Revenue
145 158 161 157 151 155 142 142 129 137 117
Operating Cost of Revenue
145 158 161 157 151 155 142 142 129 137 117
Total Operating Expenses
48 41 34 34 33 32 35 30 30 25 29
Selling, General & Admin Expense
37 41 34 34 33 32 35 30 30 25 29
Research & Development Expense
11 - - - - - - - - - -
Total Other Income / (Expense), net
-2.96 -8.30 -14 -6.29 -6.20 -6.25 -6.34 -6.30 -0.76 -4.04 -2.95
Interest & Investment Income
-3.15 - -6.22 -5.86 - - -5.99 -5.92 - - -
Other Income / (Expense), net
0.19 -0.97 -0.34 -0.44 -0.44 -0.30 -0.35 -0.38 4.72 -0.43 -0.43
Income Tax Expense
0.65 3.41 6.57 -0.27 -1.35 -5.44 -3.84 8.10 1.29 -0.43 -2.40
Basic Earnings per Share
$0.27 ($0.07) ($0.34) $0.04 ($0.09) $0.22 ($0.51) ($0.37) ($0.14) ($0.21) ($0.46)
Weighted Average Basic Shares Outstanding
35.41M 35.27M 35.26M 34.99M 34.84M 34.52M 33.94M 32.54M 32.46M 64.57M 32.17M
Diluted Earnings per Share
$0.26 ($0.07) ($0.34) $0.04 ($0.09) $0.22 ($0.51) ($0.37) ($0.14) ($0.21) ($0.46)
Weighted Average Diluted Shares Outstanding
35.41M 35.27M 35.26M 34.99M 34.84M 34.52M 33.94M 32.54M 32.46M 64.57M 32.17M
Weighted Average Basic & Diluted Shares Outstanding
35.41M 35.27M 35.26M 34.99M 34.84M 34.52M 33.94M 32.54M 32.46M 64.57M 32.17M

Annual Cash Flow Statements for Astronics

This table details how cash moves in and out of Astronics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
7.12 -2.47 -16 -11 8.51 15 -0.92 0.01 -0.66 -2.64 -33
Net Cash From Operating Activities
31 -24 -28 -5.53 37 43 55 38 49 79 100
Net Cash From Continuing Operating Activities
31 -24 -28 -5.53 37 43 55 38 49 79 100
Net Income / (Loss) Continuing Operations
-16 -26 -36 -26 -116 52 47 20 48 67 56
Consolidated Net Income / (Loss)
-16 -26 -36 -26 -116 52 47 20 48 67 56
Depreciation Expense
24 26 28 29 32 33 35 27 26 25 27
Amortization Expense
3.19 3.02 0.00 0.00 - - - - - - -
Non-Cash Adjustments To Reconcile Net Income
51 35 13 17 110 -9.95 6.70 21 4.85 5.17 3.96
Changes in Operating Assets and Liabilities, net
-32 -61 -33 -26 12 -32 -34 -30 -30 -19 12
Net Cash From Investing Activities
-8.43 -4.11 14 3.18 -5.80 65 -20 -130 -15 -74 -109
Net Cash From Continuing Investing Activities
-8.43 -4.11 14 3.18 -5.80 65 -20 -130 -15 -74 -109
Purchase of Property, Plant & Equipment
-8.43 -7.64 -7.68 -6.03 -7.46 -12 -16 -13 -13 -19 -41
Divestitures
0.00 3.54 22 9.21 0.00 107 0.00 0.00 - - -
Net Cash From Financing Activities
-15 25 -1.41 -7.51 -25 -92 -36 91 -35 -6.73 -23
Net Cash From Continuing Financing Activities
-15 25 -1.41 -7.51 -25 -92 -36 91 -35 -6.73 -23
Repayment of Debt
-392 -138 -127 -30 -171 -156 -73 -24 -42 -68 -276
Issuance of Debt
377 140 126 20 155 117 35 147 20 55 246
Issuance of Common Equity
0.00 21 0.00 0.00 - - - - - - -
Other Financing Activities, net
-0.24 2.48 0.10 2.50 -1.26 -2.29 2.20 - 4.65 5.97 7.11
Other Net Changes in Cash
-0.49 - - - - - - 0.37 - - -
Cash Interest Paid
19 18 7.61 5.95 5.83 5.71 9.71 4.78 4.54 4.73 7.82
Cash Income Taxes Paid
3.54 1.96 -9.98 -1.25 -1.54 27 12 11 16 33 27

Quarterly Cash Flow Statements for Astronics

This table details how cash moves in and out of Astronics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/29/2025 12/31/2024 9/28/2024 6/29/2024 3/30/2024 12/31/2023 9/30/2023 7/1/2023 4/1/2023 12/31/2022 10/1/2022
Net Change in Cash & Equivalents
7.52 12 1.97 -2.22 -4.70 3.66 3.36 -1.42 -8.06 11 -8.12
Net Cash From Operating Activities
21 26 8.37 -6.26 2.04 -1.67 -1.13 -1.97 -19 11 -29
Net Cash From Continuing Operating Activities
21 26 8.37 -6.26 2.04 -1.67 -1.13 -1.97 -19 11 -29
Net Income / (Loss) Continuing Operations
9.53 -2.83 -12 1.53 -3.18 6.98 -17 -12 -4.42 -6.78 -15
Consolidated Net Income / (Loss)
9.53 -2.83 -12 1.53 -3.18 6.98 -17 -12 -4.42 -6.78 -15
Depreciation Expense
5.59 5.89 6.04 6.20 6.33 6.35 6.39 6.71 6.66 6.87 6.82
Amortization Expense
0.60 0.48 1.02 0.86 0.83 0.88 0.79 0.75 0.62 - -
Non-Cash Adjustments To Reconcile Net Income
12 18 17 5.63 11 12 17 4.63 1.47 4.96 8.23
Changes in Operating Assets and Liabilities, net
-6.71 4.56 -3.69 -20 -13 -28 -8.30 -2.06 -24 5.77 -29
Net Cash From Investing Activities
-2.11 -3.18 -1.85 -1.80 -1.60 -1.50 -2.23 -2.24 1.86 -3.31 -1.79
Net Cash From Continuing Investing Activities
-2.11 -3.18 -1.85 -1.80 -1.60 -1.50 -2.23 -2.24 1.86 -3.31 -1.79
Purchase of Property, Plant & Equipment
-2.11 -3.18 -1.85 -1.80 -1.60 -1.61 -2.23 -2.23 -1.57 -3.39 -1.79
Net Cash From Financing Activities
-11 -11 -4.71 5.85 -5.04 6.66 6.83 2.77 9.18 3.54 23
Net Cash From Continuing Financing Activities
-11 -11 -4.71 5.85 -5.04 6.66 6.83 2.77 9.18 3.54 23
Repayment of Debt
-11 -195 -185 -3.29 -8.06 -5.56 -13 -2.83 -116 -13 -34
Issuance of Debt
1.14 181 181 14 1.36 4.00 4.00 5.61 126 16 57
Other Financing Activities, net
-1.73 2.98 0.02 -4.90 1.66 -0.00 3.11 -0.01 -0.61 0.08 -0.03
Effect of Exchange Rate Changes
0.35 - 0.16 -0.01 -0.10 0.18 -0.12 0.02 0.08 0.16 -0.29
Cash Interest Paid
2.72 3.98 - - - 3.55 - - - - -
Cash Income Taxes Paid
0.83 -0.44 - - - -0.23 - - - - -

Annual Balance Sheets for Astronics

This table presents Astronics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets
649 634 615 609 620 783 775 736 604 609 563
Total Current Assets
426 390 365 340 317 343 374 315 255 250 246
Cash & Equivalents
9.29 4.76 14 30 40 32 17 18 18 19 21
Restricted Cash
9.14 6.56 0.00 - - - - - - - -
Accounts Receivable
191 172 148 107 93 148 182 133 109 95 89
Inventories, net
200 192 188 158 157 146 139 150 117 115 115
Prepaid Expenses
17 15 16 45 26 16 17 15 11 21 13
Plant, Property, & Equipment, net
81 85 91 95 107 112 121 126 123 125 116
Total Noncurrent Assets
142 159 159 174 196 327 280 295 226 235 201
Goodwill
58 58 58 58 58 145 125 126 115 115 100
Intangible Assets
52 65 79 94 110 127 133 153 98 108 95
Other Noncurrent Operating Assets
31 35 22 21 28 55 21 16 13 11 5.63
Total Liabilities & Shareholders' Equity
649 634 615 609 620 783 775 736 604 609 563
Total Liabilities
393 384 375 353 349 394 388 406 267 309 335
Total Current Liabilities
156 143 152 119 94 121 128 103 87 104 109
Short-Term Debt
0.00 9.00 4.50 0.00 - 0.22 1.87 2.69 2.64 2.58 2.80
Accounts Payable
43 61 64 35 26 61 66 55 36 39 40
Accrued Expenses
41 21 24 27 20 - - - - - -
Current Deferred Revenue
27 22 33 27 25 31 27 20 23 39 45
Current Deferred & Payable Income Tax Liabilities
6.68 3.05 6.41 2.62 1.02 1.08 0.31 0.26 0.06 0.20 1.90
Current Employee Benefit Liabilities
33 22 16 20 16 22 32 25 25 24 20
Other Current Liabilities
4.70 5.07 4.44 6.78 5.00 4.52 0.91 0.00 - - -
Total Noncurrent Liabilities
237 241 223 234 256 273 260 303 180 205 226
Long-Term Debt
169 159 160 163 173 188 232 269 145 167 180
Noncurrent Deferred & Payable Income Tax Liabilities
1.43 1.31 1.87 1.42 2.91 3.92 3.20 5.12 11 15 21
Noncurrent Employee Benefit Liabilities
24 29 27 31 32 27 23 26 22 21 22
Other Noncurrent Operating Liabilities
42 51 36 38 47 54 1.92 2.91 1.41 1.67 2.79
Total Equity & Noncontrolling Interests
256 250 240 257 270 389 387 330 337 301 228
Total Preferred & Common Equity
256 250 240 257 270 389 387 330 337 301 228
Total Common Equity
256 250 240 257 270 389 386 330 337 300 228
Common Stock
145 130 99 92 82 77 73 68 65 58 50
Retained Earnings
192 210 240 287 313 429 377 325 306 257 190
Treasury Stock
-77 -81 -90 -109 -109 -101 -50 -50 -18 0.00 -
Accumulated Other Comprehensive Income / (Loss)
-3.86 -9.43 -9.53 -14 -16 -16 -13 -13 -15 -15 -12

Quarterly Balance Sheets for Astronics

This table presents Astronics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/29/2025 9/28/2024 6/29/2024 3/30/2024 9/30/2023 7/1/2023 4/1/2023 10/1/2022
Total Assets
662 652 645 630 631 654 616 599
Total Current Assets
432 424 412 392 381 398 374 347
Cash & Equivalents
25 5.18 2.86 5.31 3.98 3.47 4.22 2.57
Restricted Cash
1.14 1.19 1.54 1.30 3.67 0.82 1.50 -
Accounts Receivable
194 193 186 170 153 171 152 134
Inventories, net
198 205 201 199 204 207 200 190
Prepaid Expenses
15 19 21 16 17 16 16 21
Plant, Property, & Equipment, net
80 81 83 84 87 88 89 91
Total Noncurrent Assets
149 146 150 154 163 168 154 161
Goodwill
58 58 58 58 58 58 58 58
Intangible Assets
50 56 59 62 69 72 76 83
Other Noncurrent Operating Assets
42 32 33 34 36 37 20 20
Total Liabilities & Shareholders' Equity
662 652 645 630 631 654 616 599
Total Liabilities
395 402 387 378 398 423 377 362
Total Current Liabilities
158 150 141 151 158 174 147 133
Accounts Payable
45 57 56 61 70 80 63 53
Current Deferred Revenue
30 19 18 20 26 27 27 29
Other Current Liabilities
82 73 66 61 54 58 49 51
Total Noncurrent Liabilities
238 252 246 227 240 249 231 228
Long-Term Debt
160 178 173 153 160 169 166 159
Other Noncurrent Operating Liabilities
78 74 73 74 80 80 65 69
Total Equity & Noncontrolling Interests
267 249 258 252 232 230 239 237
Total Preferred & Common Equity
267 249 258 252 232 230 239 237
Total Common Equity
267 249 258 252 232 230 239 237
Common Stock
0.38 0.38 0.38 0.38 0.37 0.36 0.36 0.35
Accumulated Other Comprehensive Income / (Loss)
-3.35 -8.46 -9.79 -9.90 -9.09 -8.44 -9.12 -17
Other Equity Adjustments
270 257 267 261 241 238 248 253

Annual Metrics And Ratios for Astronics

This table displays calculated financial ratios and metrics derived from Astronics' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
15.41% 28.85% 20.23% -11.48% -34.96% -3.80% 28.63% -1.37% -8.55% 4.73% 94.46%
EBITDA Growth
98.67% 253.01% -16.31% 111.99% -168.67% 10.79% 68.96% -41.96% -20.29% 8.28% 114.78%
EBIT Growth
913.91% 85.36% -1.07% 80.93% -241.94% 20.09% 104.19% -58.49% -25.97% 13.09% 106.51%
NOPAT Growth
496.73% 77.80% -4.78% 71.53% -5,541.54% -97.73% 125.46% -52.05% -25.07% 13.42% 105.49%
Net Income Growth
38.63% 26.09% -39.76% 77.91% -322.58% 11.14% 137.83% -59.36% -27.70% 19.23% 106.01%
EPS Growth
42.50% 27.93% -35.37% 78.19% -335.00% 13.48% 143.10% -58.57% -36.94% 19.23% 106.01%
Operating Cash Flow Growth
227.62% 15.41% -411.97% -114.81% -12.54% -22.22% 45.25% -22.66% -37.77% -21.40% 101.57%
Free Cash Flow Firm Growth
188.84% 1.69% -206.41% -109.92% 65.99% -24.69% 161.81% -348.85% 310.48% 182.62% 92.27%
Invested Capital Growth
-0.02% 4.18% 0.08% -3.25% -25.88% -7.01% 0.15% 24.83% 3.59% 15.76% 22.95%
Revenue Q/Q Growth
1.69% 5.70% 8.54% 0.28% -14.26% -0.58% 4.10% 2.84% -0.51% -1.25% 10.10%
EBITDA Q/Q Growth
-0.81% 77.66% -41.17% 291.38% 31.99% -35.48% 37.69% -30.09% -0.72% -6.84% 16.40%
EBIT Q/Q Growth
1.77% 78.79% -32.52% 26.57% 25.32% -44.50% 72.59% -46.30% -0.77% -8.78% 20.02%
NOPAT Q/Q Growth
4.31% 62.14% 15.66% -12.89% 23.76% -97.07% 41.80% -37.79% -5.48% -5.85% 22.84%
Net Income Q/Q Growth
-153.08% 34.24% -30.64% 45.77% 10.84% -47.23% 63.28% -44.12% -7.67% -6.34% 27.31%
EPS Q/Q Growth
-170.59% 34.96% -32.14% 46.41% 8.29% -49.84% 58.43% -53.97% -22.65% -6.34% 27.31%
Operating Cash Flow Q/Q Growth
1,134.99% -109.23% -8.18% 56.38% -15.07% -38.81% 78.02% -17.89% -19.22% 5.37% 18.97%
Free Cash Flow Firm Q/Q Growth
280.83% -66.84% -28.12% -181.00% 18.13% -52.17% 166.28% -524.18% -20.26% 145.20% 84.57%
Invested Capital Q/Q Growth
-3.67% 3.22% -0.86% -2.98% -5.89% -6.28% -6.34% 16.92% -2.59% -3.96% -2.25%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
21.16% 17.53% 13.37% 14.69% 19.27% 20.21% 22.50% 21.96% 25.19% 27.15% 25.27%
EBITDA Margin
6.53% 3.79% 1.38% 1.99% -14.69% 13.91% 12.08% 9.20% 15.63% 17.93% 17.34%
Operating Margin
3.33% -0.97% -5.62% -6.44% -20.04% 0.22% 7.93% 5.14% 11.83% 14.27% 13.22%
EBIT Margin
3.05% -0.43% -3.81% -4.53% -21.03% 9.63% 7.72% 4.86% 11.55% 14.27% 13.22%
Profit (Net Income) Margin
-2.04% -3.83% -6.68% -5.75% -23.04% 6.73% 5.83% 3.15% 7.65% 9.67% 8.50%
Tax Burden Percent
206.11% 100.42% 119.98% 94.87% 103.00% 76.16% 89.52% 78.74% 70.40% 71.21% 71.01%
Interest Burden Percent
-32.40% 882.03% 146.25% 133.76% 106.38% 91.75% 84.34% 82.32% 94.05% 95.19% 90.55%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 23.84% 10.48% 21.26% 29.60% 28.79% 28.99%
Return on Invested Capital (ROIC)
4.56% -1.17% -5.39% -5.06% -14.89% 0.23% 9.76% 4.81% 11.47% 16.72% 17.54%
ROIC Less NNEP Spread (ROIC-NNEP)
-18.06% -15.34% -15.78% -9.21% -46.41% 28.98% 5.25% 1.89% 8.42% 14.56% 13.73%
Return on Net Nonoperating Assets (RNNOA)
-10.97% -9.62% -9.01% -4.64% -20.23% 13.19% 3.31% 1.09% 3.71% 8.61% 10.56%
Return on Equity (ROE)
-6.41% -10.80% -14.40% -9.71% -35.13% 13.42% 13.06% 5.90% 15.18% 25.34% 28.11%
Cash Return on Invested Capital (CROIC)
4.58% -5.26% -5.47% -1.76% 14.83% 7.50% 9.61% -17.28% 7.94% 2.11% -3.04%
Operating Return on Assets (OROA)
3.79% -0.48% -3.33% -3.28% -15.07% 9.56% 8.21% 4.53% 12.05% 16.86% 16.57%
Return on Assets (ROA)
-2.53% -4.23% -5.84% -4.16% -16.51% 6.68% 6.20% 2.94% 7.98% 11.43% 10.66%
Return on Common Equity (ROCE)
-6.41% -10.80% -14.40% -9.70% -35.11% 13.41% 13.05% 5.89% 15.17% 25.31% 28.07%
Return on Equity Simple (ROE_SIMPLE)
-6.33% -10.59% -14.90% -9.97% -42.82% 13.38% 12.11% 5.96% 14.35% 22.29% 24.62%
Net Operating Profit after Tax (NOPAT)
19 -4.67 -21 -20 -70 1.30 57 25 53 70 62
NOPAT Margin
2.33% -0.68% -3.93% -4.51% -14.03% 0.17% 7.10% 4.05% 8.33% 10.16% 9.38%
Net Nonoperating Expense Percent (NNEP)
22.62% 14.16% 10.38% 4.14% 31.52% -28.76% 4.51% 2.92% 3.05% 2.16% 3.81%
Return On Investment Capital (ROIC_SIMPLE)
4.36% -1.12% -5.21% -4.78% -15.90% 0.22% 9.18% 4.20% 10.86% 14.96% 15.09%
Cost of Revenue to Revenue
78.84% 82.47% 86.63% 85.31% 80.73% 79.79% 77.50% 78.04% 74.81% 72.85% 74.73%
SG&A Expenses to Revenue
17.84% 18.49% 18.99% 22.26% 21.99% 18.55% 14.57% 14.22% 13.36% 12.88% 12.05%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
17.84% 18.49% 18.99% 21.14% 39.31% 19.99% 14.57% 16.82% 13.36% 12.88% 12.05%
Earnings before Interest and Taxes (EBIT)
24 -2.98 -20 -20 -106 74 62 30 73 99 87
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
52 26 7.41 8.85 -74 107 97 57 99 124 115
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.20 2.37 1.38 1.47 1.51 2.22 2.55 3.52 2.91 3.46 10.57
Price to Tangible Book Value (P/TBV)
3.87 4.70 3.23 3.63 4.00 7.40 7.69 23.02 7.94 13.57 73.52
Price to Revenue (P/Rev)
0.71 0.86 0.62 0.85 0.81 1.12 1.23 1.86 1.55 1.50 3.65
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 16.59 21.02 59.01 20.29 15.52 42.91
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 6.03% 4.76% 1.69% 4.93% 6.44% 2.33%
Enterprise Value to Invested Capital (EV/IC)
1.75 1.84 1.23 1.31 1.34 1.87 2.05 2.42 2.38 2.64 6.59
Enterprise Value to Revenue (EV/Rev)
0.90 1.09 0.90 1.15 1.07 1.32 1.50 2.27 1.76 1.72 3.89
Enterprise Value to EBITDA (EV/EBITDA)
13.73 28.62 65.03 57.72 0.00 9.48 12.38 24.64 11.25 9.59 22.44
Enterprise Value to EBIT (EV/EBIT)
29.37 0.00 0.00 0.00 0.00 13.69 19.38 46.61 15.22 12.05 29.44
Enterprise Value to NOPAT (EV/NOPAT)
38.49 0.00 0.00 0.00 0.00 786.79 21.08 55.98 21.11 16.92 41.46
Enterprise Value to Operating Cash Flow (EV/OCF)
23.33 0.00 0.00 0.00 14.47 23.88 21.89 37.45 22.78 15.17 25.75
Enterprise Value to Free Cash Flow (EV/FCFF)
38.28 0.00 0.00 0.00 7.69 24.10 21.40 0.00 30.49 133.90 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.66 0.67 0.68 0.64 0.64 0.48 0.61 0.82 0.44 0.57 0.80
Long-Term Debt to Equity
0.66 0.64 0.66 0.64 0.64 0.48 0.60 0.82 0.43 0.56 0.79
Financial Leverage
0.61 0.63 0.57 0.50 0.44 0.45 0.63 0.58 0.44 0.59 0.77
Leverage Ratio
2.54 2.55 2.47 2.33 2.13 2.01 2.11 2.01 1.90 2.22 2.64
Compound Leverage Factor
-0.82 22.51 3.61 3.12 2.26 1.84 1.78 1.65 1.79 2.11 2.39
Debt to Total Capital
39.71% 40.27% 40.60% 38.85% 39.02% 32.62% 37.70% 45.17% 30.50% 36.10% 44.51%
Short-Term Debt to Total Capital
0.00% 2.15% 1.11% 0.00% 0.00% 0.04% 0.30% 0.45% 0.54% 0.55% 0.68%
Long-Term Debt to Total Capital
39.71% 38.12% 39.49% 38.85% 39.02% 32.58% 37.40% 44.72% 29.96% 35.55% 43.83%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
60.29% 59.73% 59.40% 61.15% 60.90% 67.38% 62.24% 54.78% 69.43% 63.84% 55.43%
Debt to EBITDA
3.25 6.43 22.14 18.42 -2.34 1.75 2.41 4.73 1.50 1.37 1.60
Net Debt to EBITDA
2.89 6.00 20.28 15.06 -1.80 1.45 2.24 4.42 1.32 1.22 1.41
Long-Term Debt to EBITDA
3.25 6.09 21.54 18.42 -2.34 1.75 2.39 4.69 1.47 1.35 1.57
Debt to NOPAT
9.10 -36.03 -7.80 -8.12 -2.45 145.30 4.11 10.75 2.81 2.41 2.95
Net Debt to NOPAT
8.11 -33.60 -7.14 -6.64 -1.88 120.67 3.81 10.04 2.47 2.15 2.61
Long-Term Debt to NOPAT
9.10 -34.10 -7.58 -8.12 -2.45 145.13 4.07 10.64 2.76 2.38 2.91
Altman Z-Score
3.12 2.93 2.25 2.36 2.09 3.72 3.88 3.67 4.70 4.57 6.77
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.07% 0.05% 0.04% 0.10% 0.10% 0.09% 0.10% 0.12%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.73 2.72 2.41 2.87 3.38 2.84 2.92 3.06 2.95 2.40 2.25
Quick Ratio
1.29 1.23 1.07 1.16 1.42 1.49 1.55 1.46 1.47 1.09 1.01
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
19 -21 -21 -6.96 70 42 56 -91 37 8.89 -11
Operating Cash Flow to CapEx
362.67% -313.36% -368.89% -91.65% 500.54% 353.30% 336.34% 280.33% 374.73% 421.12% 244.30%
Free Cash Flow to Firm to Interest Expense
1.84 0.00 0.00 -1.02 10.41 6.89 5.78 -16.92 8.38 1.87 -1.30
Operating Cash Flow to Interest Expense
3.01 0.00 0.00 -0.81 5.54 6.95 5.65 7.04 11.22 16.52 12.10
Operating Cash Flow Less CapEx to Interest Expense
2.18 0.00 0.00 -1.70 4.43 4.98 3.97 4.53 8.23 12.60 7.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.24 1.10 0.87 0.72 0.72 0.99 1.06 0.93 1.04 1.18 1.25
Accounts Receivable Turnover
4.38 4.31 4.19 4.44 4.17 4.68 5.10 5.16 6.19 7.52 8.82
Inventory Turnover
3.20 2.99 2.68 2.41 2.68 4.33 4.31 3.65 4.08 4.38 4.93
Fixed Asset Turnover
9.58 7.83 5.75 4.41 4.59 6.62 6.51 5.02 5.12 5.74 7.06
Accounts Payable Turnover
12.05 9.07 9.36 12.38 9.28 9.68 10.22 10.66 12.70 12.86 13.45
Days Sales Outstanding (DSO)
83.41 84.71 87.08 82.24 87.53 78.01 71.55 70.74 59.00 48.55 41.37
Days Inventory Outstanding (DIO)
113.95 121.94 136.10 151.29 136.22 84.20 84.68 99.91 89.41 83.42 74.01
Days Payable Outstanding (DPO)
30.29 40.24 39.01 29.48 39.32 37.70 35.72 34.23 28.75 28.38 27.14
Cash Conversion Cycle (CCC)
167.07 166.41 184.17 204.05 184.43 124.52 120.52 136.42 119.67 103.59 88.23
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
406 406 390 390 403 544 585 584 468 451 390
Invested Capital Turnover
1.96 1.73 1.37 1.12 1.06 1.37 1.38 1.19 1.38 1.65 1.87
Increase / (Decrease) in Invested Capital
-0.10 16 0.30 -13 -141 -41 0.85 116 16 61 73
Enterprise Value (EV)
713 748 482 511 540 1,019 1,201 1,415 1,113 1,191 2,572
Market Capitalization
563 591 331 378 407 863 984 1,161 983 1,039 2,410
Book Value per Share
$7.26 $7.35 $7.46 $8.16 $8.77 $12.60 $11.95 $11.77 $11.61 $11.76 $5.23
Tangible Book Value per Share
$4.13 $3.71 $3.19 $3.31 $3.31 $3.78 $3.96 $1.80 $4.26 $3.00 $0.75
Total Capital
425 418 404 420 443 577 621 602 486 470 411
Total Debt
169 168 164 163 173 188 234 272 148 170 183
Total Long-Term Debt
169 159 160 163 173 188 232 269 145 167 180
Net Debt
150 157 150 133 133 156 217 254 130 151 162
Capital Expenditures (CapEx)
8.43 7.64 7.68 6.03 7.46 12 16 13 13 19 41
Debt-free, Cash-free Net Working Capital (DFCFNWC)
252 244 204 191 183 191 231 197 153 130 118
Debt-free Net Working Capital (DFNWC)
270 255 218 221 223 223 248 215 171 148 139
Net Working Capital (NWC)
270 246 214 221 223 222 246 212 169 146 137
Net Nonoperating Expense (NNE)
35 22 15 5.51 45 -51 10 5.60 4.29 3.38 5.86
Net Nonoperating Obligations (NNO)
150 157 150 133 133 155 198 254 130 151 162
Total Depreciation and Amortization (D&A)
28 29 28 29 32 33 35 27 26 25 27
Debt-free, Cash-free Net Working Capital to Revenue
31.63% 35.42% 38.21% 43.04% 36.37% 24.69% 28.80% 31.58% 24.21% 18.74% 17.88%
Debt-free Net Working Capital to Revenue
33.95% 37.06% 40.79% 49.73% 44.41% 28.82% 30.87% 34.45% 27.03% 21.42% 21.09%
Net Working Capital to Revenue
33.95% 35.76% 39.95% 49.73% 44.41% 28.79% 30.64% 34.02% 26.62% 21.05% 20.66%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.46) ($0.80) ($1.11) ($0.82) ($3.76) $1.62 $1.45 $0.69 $1.66 $2.36 $2.04
Adjusted Weighted Average Basic Shares Outstanding
35.27M 34.52M 64.57M 31.52M 30.89M 30.72M 32.60M 28.07M 29.10M 28.58M 55.85M
Adjusted Diluted Earnings per Share
($0.46) ($0.80) ($1.11) ($0.82) ($3.76) $1.60 $1.41 $0.67 $1.61 $2.28 $1.95
Adjusted Weighted Average Diluted Shares Outstanding
35.27M 34.52M 64.57M 31.52M 30.89M 30.72M 32.60M 28.07M 29.10M 28.58M 55.85M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
35.27M 34.52M 64.57M 31.52M 30.89M 30.72M 32.60M 28.07M 29.10M 28.58M 55.85M
Normalized Net Operating Profit after Tax (NOPAT)
19 -4.67 -21 -24 -9.58 9.74 57 38 53 70 62
Normalized NOPAT Margin
2.33% -0.68% -3.93% -5.30% -1.91% 1.26% 7.10% 6.10% 8.33% 10.16% 9.38%
Pre Tax Income Margin
-0.99% -3.82% -5.57% -6.06% -22.37% 8.84% 6.51% 4.00% 10.86% 13.59% 11.97%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.39 0.00 0.00 -2.96 -15.68 12.12 6.38 5.65 16.80 20.80 10.58
NOPAT to Interest Expense
1.83 0.00 0.00 -2.95 -10.46 0.21 5.87 4.71 12.11 14.81 7.51
EBIT Less CapEx to Interest Expense
1.56 0.00 0.00 -3.85 -16.78 10.15 4.70 3.14 13.80 16.87 5.63
NOPAT Less CapEx to Interest Expense
1.00 0.00 0.00 -3.84 -11.56 -1.76 4.19 2.20 9.11 10.89 2.56
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -6.68% 97.63% 0.00% 164.55% 36.38% 0.00% 0.00%

Quarterly Metrics And Ratios for Astronics

This table displays calculated financial ratios and metrics derived from Astronics' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/29/2025 12/31/2024 9/28/2024 6/29/2024 3/30/2024 12/31/2023 9/30/2023 7/1/2023 4/1/2023 12/31/2022 10/1/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.27% 6.78% 25.03% 13.56% 18.23% 23.48% 23.95% 35.10% 34.74% 36.28% 17.52%
EBITDA Growth
132.59% -2.87% 297.05% 49.65% -12.81% 349.05% 3.37% 661.71% -29.98% -61.28% -490.92%
EBIT Growth
983.25% 5.64% 154.16% 252.58% -47.55% 307.92% -0.58% 123.23% -64.76% -356.82% -192.25%
NOPAT Growth
954.95% -223.31% 157.84% 448.12% 170.30% 1,696.34% -1.15% 128.54% -164.50% 63.78% -218.23%
Net Income Growth
399.81% -140.60% 30.88% 112.78% 28.02% 202.91% -14.31% -8.98% -42.37% -522.63% -107.10%
EPS Growth
388.89% -131.82% 33.33% 110.81% 35.71% 204.76% -10.87% -8.82% -40.00% -450.00% -100.00%
Operating Cash Flow Growth
913.35% 1,678.08% 844.18% -217.77% 110.62% -115.46% 96.10% 81.50% -6,169.94% -16.51% -78.26%
Free Cash Flow Firm Growth
3,604.49% -328.04% -114.13% 44.78% 98.44% 860.12% -498.99% -402.62% -206.46% -135.93% -107.45%
Invested Capital Growth
-1.56% -0.02% 7.13% 5.85% 0.42% 4.18% 0.06% 7.40% 8.71% 0.08% -2.06%
Revenue Q/Q Growth
-1.25% 2.38% 2.82% 7.05% -5.23% 19.87% -6.61% 11.45% -1.02% 20.33% 1.79%
EBITDA Q/Q Growth
36.65% -5.36% 6.40% 69.02% -42.93% 292.01% -180.80% -1.53% 193.92% 141.32% -369.71%
EBIT Q/Q Growth
68.59% -1.59% 12.87% 478.46% -83.56% 150.46% -834.74% -13.94% 165.18% 75.59% -69.69%
NOPAT Q/Q Growth
128.19% -844.49% -36.24% 688.30% -96.70% 449.17% -704.30% 201.10% 25.17% 77.87% -70.49%
Net Income Q/Q Growth
436.44% 75.87% -865.69% 148.24% -145.56% 141.08% -41.54% -171.78% 34.87% 54.37% -34.94%
EPS Q/Q Growth
471.43% 79.41% -950.00% 144.44% -140.91% 143.14% -37.84% -164.29% 33.33% 54.35% -35.29%
Operating Cash Flow Q/Q Growth
-21.86% 215.54% 233.74% -407.31% 221.68% -48.80% 42.89% 89.73% -277.13% 137.59% -170.63%
Free Cash Flow Firm Q/Q Growth
142.80% -96.13% -53.84% -2,613.40% -102.79% 284.17% 60.33% 23.49% -1,259.61% -45.13% -120.04%
Invested Capital Q/Q Growth
-1.33% -3.67% -1.31% 4.95% 0.20% 3.22% -2.49% -0.43% 3.95% -0.86% 4.66%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
29.55% 24.00% 20.98% 20.87% 18.47% 20.47% 12.66% 18.74% 17.57% 13.60% 10.95%
EBITDA Margin
9.48% 6.85% 7.41% 7.16% 4.53% 7.53% -4.70% 5.43% 6.15% 2.07% -6.03%
Operating Margin
6.38% 4.26% 4.11% 3.81% 0.90% 3.98% -8.89% 1.37% -1.51% -2.00% -10.89%
EBIT Margin
6.47% 3.79% 3.94% 3.59% 0.66% 3.83% -9.10% 1.16% 1.50% -2.28% -11.22%
Profit (Net Income) Margin
4.63% -1.36% -5.76% 0.77% -1.72% 3.57% -10.42% -6.88% -2.82% -4.29% -11.30%
Tax Burden Percent
93.65% -491.67% 226.91% 121.76% 70.17% 454.76% 81.58% 307.51% 141.28% 94.05% 86.08%
Interest Burden Percent
76.36% 7.29% -64.41% 17.70% -368.21% 20.51% 140.41% -193.36% -133.26% 200.33% 117.09%
Effective Tax Rate
6.35% 591.67% 0.00% -21.76% 0.00% -354.76% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
12.07% -40.96% 5.52% 8.28% 1.11% 31.36% -10.31% 1.53% -1.57% -1.92% -9.45%
ROIC Less NNEP Spread (ROIC-NNEP)
10.15% -14.39% -5.02% 3.81% -1.58% 12.86% -14.61% -7.63% -3.54% -5.14% -12.60%
Return on Net Nonoperating Assets (RNNOA)
5.67% -8.74% -3.48% 2.68% -1.04% 8.07% -9.89% -4.74% -1.98% -2.94% -7.91%
Return on Equity (ROE)
17.74% -49.70% 2.04% 10.95% 0.07% 39.42% -20.20% -3.21% -3.55% -4.86% -17.35%
Cash Return on Invested Capital (CROIC)
-3.25% 4.58% -2.53% -5.26% -0.87% -5.26% -3.19% -10.27% -13.43% -5.47% -4.19%
Operating Return on Assets (OROA)
8.17% 4.70% 4.81% 4.10% 0.77% 4.23% -9.65% 1.16% 1.43% -1.99% -9.14%
Return on Assets (ROA)
5.85% -1.68% -7.03% 0.88% -1.98% 3.94% -11.05% -6.91% -2.69% -3.75% -9.21%
Return on Common Equity (ROCE)
17.74% -49.70% 2.04% 10.95% 0.07% 39.42% -20.20% -3.21% -3.55% -4.86% -17.35%
Return on Equity Simple (ROE_SIMPLE)
-1.32% 0.00% -2.57% -4.52% -10.00% 0.00% -17.29% -16.51% -15.51% 0.00% -11.54%
Net Operating Profit after Tax (NOPAT)
12 -44 5.86 9.19 1.17 35 -10 1.68 -1.66 -2.22 -10
NOPAT Margin
5.97% -20.93% 2.88% 4.64% 0.63% 18.12% -6.22% 0.96% -1.06% -1.40% -7.62%
Net Nonoperating Expense Percent (NNEP)
1.92% -26.57% 10.54% 4.47% 2.70% 18.50% 4.31% 9.16% 1.97% 3.22% 3.16%
Return On Investment Capital (ROIC_SIMPLE)
2.88% -10.27% 1.37% 2.13% 0.28% 8.47% -2.53% 0.41% -0.40% -0.55% -2.53%
Cost of Revenue to Revenue
70.45% 76.00% 79.02% 79.13% 81.53% 79.53% 87.34% 81.26% 82.43% 86.40% 89.05%
SG&A Expenses to Revenue
17.79% 19.75% 16.87% 17.06% 17.57% 16.48% 21.54% 17.37% 19.09% 15.60% 21.84%
R&D to Revenue
5.37% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.17% 19.75% 16.87% 17.06% 17.57% 16.48% 21.54% 17.37% 19.09% 15.60% 21.84%
Earnings before Interest and Taxes (EBIT)
13 7.90 8.03 7.12 1.23 7.48 -15 2.02 2.35 -3.60 -15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
20 14 15 14 8.39 15 -7.66 9.48 9.62 3.27 -7.92
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.26 2.20 2.82 2.71 2.61 2.37 2.22 2.80 3.61 1.38 1.06
Price to Tangible Book Value (P/TBV)
5.47 3.87 5.18 4.95 5.00 4.70 4.89 6.44 8.21 3.23 2.62
Price to Revenue (P/Rev)
1.07 0.71 0.90 0.94 0.92 0.86 0.79 1.04 1.50 0.62 0.51
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.50 1.75 2.07 2.03 2.00 1.84 1.72 2.03 2.54 1.23 1.04
Enterprise Value to Revenue (EV/Rev)
1.23 0.90 1.12 1.17 1.13 1.09 1.04 1.32 1.79 0.90 0.83
Enterprise Value to EBITDA (EV/EBITDA)
15.92 13.73 16.70 29.29 32.63 28.62 46.03 56.62 313.22 65.03 32.40
Enterprise Value to EBIT (EV/EBIT)
27.61 29.37 36.64 868.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 38.49 49.22 491.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
20.42 23.33 353.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 38.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.60 0.66 0.72 0.67 0.64 0.67 0.73 0.77 0.72 0.68 0.67
Long-Term Debt to Equity
0.60 0.66 0.72 0.67 0.61 0.64 0.69 0.73 0.69 0.66 0.67
Financial Leverage
0.56 0.61 0.69 0.70 0.66 0.63 0.68 0.62 0.56 0.57 0.63
Leverage Ratio
2.49 2.54 2.66 2.66 2.54 2.55 2.62 2.57 2.41 2.47 2.47
Compound Leverage Factor
1.90 0.18 -1.72 0.47 -9.35 0.52 3.68 -4.97 -3.22 4.94 2.90
Debt to Total Capital
37.51% 39.71% 41.80% 40.28% 39.18% 40.27% 42.10% 43.54% 41.91% 40.60% 40.14%
Short-Term Debt to Total Capital
0.00% 0.00% 0.13% 0.30% 2.17% 2.15% 2.24% 2.20% 1.64% 1.11% 0.00%
Long-Term Debt to Total Capital
37.51% 39.71% 41.67% 39.98% 37.00% 38.12% 39.86% 41.35% 40.27% 39.49% 40.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
62.49% 60.29% 58.20% 59.72% 60.82% 59.73% 57.90% 56.46% 58.09% 59.40% 59.86%
Debt to EBITDA
2.54 3.25 3.42 5.87 6.51 6.43 11.48 12.30 52.45 22.14 12.63
Net Debt to EBITDA
2.13 2.89 3.30 5.72 6.24 6.00 10.96 12.00 50.71 20.28 12.43
Long-Term Debt to EBITDA
2.54 3.25 3.41 5.83 6.15 6.09 10.87 11.68 50.40 21.54 12.63
Debt to NOPAT
-8.22 9.10 10.08 98.64 -87.91 -36.03 -13.70 -14.54 -8.72 -7.80 -6.38
Net Debt to NOPAT
-6.89 8.11 9.72 96.15 -84.32 -33.60 -13.08 -14.19 -8.43 -7.14 -6.27
Long-Term Debt to NOPAT
-8.22 9.10 10.05 97.90 -83.03 -34.10 -12.97 -13.81 -8.38 -7.58 -6.38
Altman Z-Score
3.12 3.04 2.79 2.77 2.65 2.98 2.16 2.29 2.76 2.34 1.59
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.74 2.73 2.83 2.92 2.59 2.72 2.41 2.29 2.55 2.41 2.60
Quick Ratio
1.39 1.29 1.32 1.34 1.16 1.23 0.99 1.00 1.07 1.07 1.02
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
19 -44 -22 -14 -0.53 19 -10 -26 -34 -2.51 -1.73
Operating Cash Flow to CapEx
980.62% 829.68% 452.54% -348.55% 127.47% -104.23% -50.43% -88.22% -1,219.39% 319.25% -1,609.55%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -3.18 0.00 -0.09 0.00 0.00 0.00 -6.24 0.00 -0.69
Operating Cash Flow to Interest Expense
0.00 0.00 1.20 0.00 0.35 0.00 0.00 0.00 -3.51 0.00 -11.44
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.93 0.00 0.08 0.00 0.00 0.00 -3.79 0.00 -12.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.26 1.24 1.22 1.14 1.15 1.10 1.06 1.00 0.95 0.87 0.82
Accounts Receivable Turnover
4.48 4.38 4.52 4.15 4.45 4.31 4.55 4.29 4.26 4.19 4.08
Inventory Turnover
3.19 3.20 3.05 2.97 2.96 2.99 2.79 2.74 2.71 2.68 2.44
Fixed Asset Turnover
9.95 9.58 9.31 8.71 8.33 7.83 7.35 6.95 6.33 5.75 5.24
Accounts Payable Turnover
11.91 12.05 9.86 8.90 9.48 9.07 8.96 8.32 9.30 9.36 10.93
Days Sales Outstanding (DSO)
81.44 83.41 80.84 87.90 82.03 84.71 80.27 85.03 85.61 87.08 89.45
Days Inventory Outstanding (DIO)
114.29 113.95 119.59 123.06 123.50 121.94 130.83 133.15 134.64 136.10 149.41
Days Payable Outstanding (DPO)
30.64 30.29 37.04 41.01 38.50 40.24 40.76 43.86 39.24 39.01 33.41
Cash Conversion Cycle (CCC)
165.10 167.07 163.39 169.95 167.03 166.41 170.34 174.32 181.02 184.17 205.44
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
401 406 422 427 407 406 394 404 406 390 394
Invested Capital Turnover
2.02 1.96 1.92 1.78 1.77 1.73 1.66 1.59 1.48 1.37 1.24
Increase / (Decrease) in Invested Capital
-6.33 -0.10 28 24 1.70 16 0.23 28 32 0.30 -8.29
Enterprise Value (EV)
1,004 713 874 867 813 748 677 818 1,029 482 408
Market Capitalization
870 563 702 698 657 591 516 645 863 331 251
Book Value per Share
$7.56 $7.26 $7.12 $7.40 $7.29 $7.35 $7.14 $7.10 $3.70 $7.46 $7.41
Tangible Book Value per Share
$4.51 $4.13 $3.87 $4.04 $3.81 $3.71 $3.24 $3.08 $1.63 $3.19 $3.01
Total Capital
427 425 428 432 414 418 401 408 411 404 396
Total Debt
160 169 179 174 162 168 169 178 172 164 159
Total Long-Term Debt
160 169 178 173 153 159 160 169 166 160 159
Net Debt
134 150 173 170 156 157 161 173 167 150 156
Capital Expenditures (CapEx)
2.11 3.18 1.85 1.80 1.60 1.61 2.23 2.23 1.57 3.39 1.79
Debt-free, Cash-free Net Working Capital (DFCFNWC)
249 252 268 268 243 244 224 229 228 204 211
Debt-free Net Working Capital (DFNWC)
275 270 275 273 250 255 232 233 234 218 214
Net Working Capital (NWC)
275 270 274 271 241 246 223 224 227 214 214
Net Nonoperating Expense (NNE)
2.77 -41 18 7.66 4.34 28 6.85 14 2.76 4.56 4.84
Net Nonoperating Obligations (NNO)
134 150 173 170 156 157 161 173 167 150 156
Total Depreciation and Amortization (D&A)
6.19 6.38 7.06 7.07 7.16 7.22 7.17 7.46 7.28 6.87 6.82
Debt-free, Cash-free Net Working Capital to Revenue
30.47% 31.63% 34.31% 36.17% 33.86% 35.42% 34.41% 36.85% 39.70% 38.21% 42.87%
Debt-free Net Working Capital to Revenue
33.65% 33.95% 35.12% 36.76% 34.78% 37.06% 35.58% 37.54% 40.70% 40.79% 43.40%
Net Working Capital to Revenue
33.65% 33.95% 35.05% 36.59% 33.52% 35.76% 34.20% 36.10% 39.52% 39.95% 43.40%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.27 ($0.07) ($0.34) $0.04 ($0.09) $0.22 ($0.51) ($0.37) ($0.14) ($0.21) ($0.46)
Adjusted Weighted Average Basic Shares Outstanding
35.41M 35.27M 35.26M 34.99M 34.84M 34.52M 33.94M 32.54M 32.46M 64.57M 32.17M
Adjusted Diluted Earnings per Share
$0.26 ($0.07) ($0.34) $0.04 ($0.09) $0.22 ($0.51) ($0.37) ($0.14) ($0.21) ($0.46)
Adjusted Weighted Average Diluted Shares Outstanding
35.41M 35.27M 35.26M 34.99M 34.84M 34.52M 33.94M 32.54M 32.46M 64.57M 32.17M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
35.41M 35.27M 35.26M 34.99M 34.84M 34.52M 33.94M 32.54M 32.46M 64.57M 32.17M
Normalized Net Operating Profit after Tax (NOPAT)
12 6.21 5.86 5.29 1.17 5.45 -10 1.68 -1.66 -2.22 -10
Normalized NOPAT Margin
5.97% 2.98% 2.88% 2.67% 0.63% 2.79% -6.22% 0.96% -1.06% -1.40% -7.62%
Pre Tax Income Margin
4.94% 0.28% -2.54% 0.64% -2.45% 0.79% -12.78% -2.24% -2.00% -4.56% -13.13%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 1.15 0.00 0.21 0.00 0.00 0.00 0.43 0.00 -5.85
NOPAT to Interest Expense
0.00 0.00 0.84 0.00 0.20 0.00 0.00 0.00 -0.30 0.00 -3.98
EBIT Less CapEx to Interest Expense
0.00 0.00 0.88 0.00 -0.06 0.00 0.00 0.00 0.14 0.00 -6.56
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.57 0.00 -0.08 0.00 0.00 0.00 -0.59 0.00 -4.69
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Astronics' Financials

When does Astronics's fiscal year end?

According to the most recent income statement we have on file, Astronics' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Astronics' net income changed over the last 10 years?

Astronics' net income appears to be on a downward trend, with a most recent value of -$16.22 million in 2024, falling from $56.17 million in 2014. The previous period was -$26.42 million in 2023.

What is Astronics's operating income?
Astronics's total operating income in 2024 was $26.47 million, based on the following breakdown:
  • Total Gross Profit: $168.34 million
  • Total Operating Expenses: $141.88 million
How has Astronics revenue changed over the last 10 years?

Over the last 10 years, Astronics' total revenue changed from $661.04 million in 2014 to $795.43 million in 2024, a change of 20.3%.

How much debt does Astronics have?

Astronics' total liabilities were at $392.67 million at the end of 2024, a 2.2% increase from 2023, and a 17.3% increase since 2014.

How much cash does Astronics have?

In the past 10 years, Astronics' cash and equivalents has ranged from $4.76 million in 2023 to $40.41 million in 2020, and is currently $9.29 million as of their latest financial filing in 2024.

How has Astronics' book value per share changed over the last 10 years?

Over the last 10 years, Astronics' book value per share changed from 5.23 in 2014 to 7.26 in 2024, a change of 38.8%.



This page (OTCMKTS:ATROB) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners